Generic drug manufacturer Zydus Pharmaceuticals USA said in a recent public notice it will pay refunds for 340B overcharges that occurred mostly in the first two quarters of 2022. The products include Zydus’ equivalents of the widely prescribed antibiotic Zithromax, hyperactivity drug Adderall, hypertension drug Cardizem, and enlarged prostrate and erectile dysfunction treatment Cialis.
The refund notice is dated Feb. 14. The U.S. Health Resources and Services Administration posted it on the Office of Pharmacy Affairs website March 3. It lists 83 Zydus generic drugs spanning a wide range of indications.
Generic drug manufacturer Zydus Pharmaceuticals USA said in a recent public notice it will pay refunds for 340B overcharges that occurred mostly in the first two quarters of 2022.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
